Contraception

Contraception for women with cardiovascular disease

April 21, 2021

Early and routine contraceptive counseling for all women of reproductive age with cardiovascular disease or cardiovascular risk factors is an essential component of comprehensive cardiovascular care, according to evidence-based recommendations of contraceptive options published in the Journal of the American College of Cardiology (JACC).

S3E5: LARC in the time of COVID-19 and telehealth: Part 2

April 07, 2021

This video interview features Rachael Phelps, MD, Medical Director at Planned Parenthood of Central and Western New York, and of the Rochester LARC Initiative; and Amber Truehart, MD, Assistant Professor of Obstetrics and Gynecology, Section of Family Planning and Contraceptive Research at the University of Chicago.

LARC in the time of COVID and telehealth: Part 1

March 31, 2021

This video interview features Rachael Phelps, MD, Medical Director at Planned Parenthood of Central and Western New York, and of the Rochester LARC Initiative; and Amber Truehart, MD, Assistant Professor of Obstetrics and Gynecology, Section of Family Planning and Contraceptive Research at the University of Chicago.

Nextstellis combined oral contraceptive and endocrine markers

March 23, 2021

Limited changes occur in endocrine markers with the combined oral contraceptive Nextstellis (Mayne Pharma), according to a prospective study presented at the virtual annual meeting of the International Society for the Study of Women's Sexual Health (ISSWSH) in March.

Medicaid payments for immediate postpartum LARC

March 02, 2021

Since 2012, when South Carolina's Medicaid program became the first state Medicaid program to separate payment for the immediate postpartum placement of long-acting reversible contraception (LARC) from global maternity payment, a significantly greater number of mothers are using LARC, especially among adolescents.

Study examines switching intentions in contraception use

March 01, 2021

When it comes to willingness to switch contraception method, a team of researchers has looked into whether method type, satisfaction with use, and confidence in correct use were independently associated with switching intentions.

Crucial Conversations for Careers in MFM

January 26, 2021

Three experts in maternal-fetal medicine hosted the Womxn’s Health Collaborative Symposium: Crucial conversations for careers in MFM during the Society for Maternal Fetal Medicine’s (SMFM) 41st Annual Pregnancy Meeting on Monday.

Contraceptive counseling via volunteer reproductive health educators

January 19, 2021

Initiation of more effective contraception occurred more often among patients who were seen by a volunteer reproductive health educator during routine visits at a resident obstetrics and gynecology clinic, according to a study published in Maternal and Child Health Journal.

Oral and IUD emergency contraception provision

November 25, 2020

Less than half of ob/gyns offer their patients the two most effective forms of emergency contraception -- ulipristal acetate and the copper intrauterine device (IUD) -- according to a national survey.

Study finds copper IUD and LNG-IUS can impact microbiota over time

November 12, 2020

Neither the levonorgestrel-releasing intrauterine system (LNG-IUS) nor the copper intrauterine device (IUD) impact the incidence of cellular atypia, but do interfere with the microbiota over time, according to liquid-based cervical cytology and microbiological analyses.